Regulus Therapeutics Stock (NASDAQ: RGLS) stock price, news, charts, stock research, profile.
Open | $1.68 |
Close | - |
Volume / Avg. | 67.63K / 829.70K |
Day Range | 1.65 - 1.71 |
52 Wk Range | 1.08 - 3.79 |
Market Cap | $109.66M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 10.29% |
Days to Cover | 1.69 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Regulus Therapeutics (NASDAQ:RGLS) through any online brokerage.
Other companies in Regulus Therapeutics’s space includes: Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), Armata Pharmaceuticals (AMEX:ARMP), FibroGen (NASDAQ:FGEN) and Vistagen Therapeutics (NASDAQ:VTGN).
There is no analysis for Regulus Therapeutics.
Regulus Therapeutics has a consensus price target of $9.50.
The stock price for Regulus Therapeutics (NASDAQ: RGLS) is $1.68 last updated Today at July 22, 2024 at 9:10 AM EDT.
There are no upcoming dividends for Regulus Therapeutics.
Regulus Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Regulus Therapeutics.
Regulus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.